Nature Reviews Drug Discovery
 | |
Abbreviated title (ISO 4) | Nat. Rev. Drug Discov. |
|---|---|
| Discipline | Pharmacology, biotechnology |
| Language | English |
| Publication details | |
| Publisher | |
Publication history | 2002-present |
| Frequency | Monthly |
| 41.908 | |
| Indexing | |
| ISSN |
1474-1776 (print) 1474-1784 (web) |
| LCCN | 2002243044 |
| CODEN | NRDDAG |
| OCLC no. | 427380493 |
| Links | |
Nature Reviews Drug Discovery is a peer-reviewed review journal covering drug discovery and development. According to the Journal Citation Reports, the journal has a 2014 impact factor of 41.908.[1]
Reviews are commissioned to specialists and supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal publishes analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces.[2]
See also
References
- ↑ "Nature Reviews Drug Discovery". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
- ↑ Guide : Information : Nature Reviews Drug Discovery. Nature.com. Retrieved on 2011-06-29.
External links
This article is issued from Wikipedia - version of the Friday, June 19, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.